Effects of thyrotropin suppression with tri-lodothyroacetic acid on radionuclide cardiovascular parameters.
Pujol
P
P
De Boisvilliers
F
F
Bringer
J
J
Jaffiol
C
C
D005260:Female; D006042:Goiter / Q000188:drug therapy*; D006331:Heart Diseases / Q000000981:diagnostic imaging*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D013972:Thyrotropin / Q000037:antagonists & inhibitors*; D014284:Triiodothyronine / Q000008:administration & dosage* / Q000009:adverse effects* / Q000031:analogs & derivatives*; D016277:Ventricular Function, Left / Q000187:drug effects*
D014284:Triiodothyronine; C010642:3,3',5-triiodothyroacetic acid; D013972:Thyrotropin